Although the difference in MTS ( 11 ) between mutation-positive and mutation-negative cases did not reach statistical significance, further studies are required to determine MTS utility in group A RAPTAS cases.
← all excerpts
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
1
—
—